ClinicalTrials.gov
public full text
Public Domain
A Study of Viracept in HIV-Positive Women
The purpose of this study is to see if it is safe and effective to give Viracept plus stavudine (d4T) plus lamivudine (3TC) to HIV-positive women with a CD4 count \<= 400 cells/mm3. This study also examines how the body handles Viracept when given with d4T and 3TC.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vicente Ferrer HIV Cohort Study#1072463
- Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management#1408490
- Effect of Supplementation With Glutamine and Exercise in Women With HIV/AIDS#1007610
- ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction#966930
- Linking Persons With HIV, Discharged From Jail, With Community Care#1261369
Record · ID 1464359
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive